HORSHAM, Pa., July 27, 2017 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatological conditions, will release second quarter financial results on Thursday, August 10, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Frank J. McCaney, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress and answer questions.
| Conference Call Details: | |
| Date: | Thursday, August 10 |
| Time: | 4:30 pm Eastern Time |
| Toll Free: | 888-299-7209 |
| International: | 719-325-4821 |
| Passcode: | 9972674 |
| Webcast: | www.strataskinsciences.com |
| Replays, available through August 24, 2017 | |
| Toll Free: | 844-512-2921 |
| International: | 412-317-6671 |
| Replay PIN: | 9972674 |
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN™ MicroSystem, marketed specifically for the intended use of micropigmentation; and Nordlys, a multi-technology aesthetic laser device.
Investor Contacts: Christina L. Allgeier STRATA Skin Sciences, Inc. 215 619 3267 [email protected] Bob Yedid LifeSci Advisors, LLC 646-597-6989 [email protected]


Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Apple Turns 50: From Garage Startup to AI Crossroads
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
First Western Ship Transits Strait of Hormuz Since Iran War Began
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



